A citation-based method for searching scientific literature

C Cybulski, B Górski, T Huzarski, B Masojć, M Mierzejewski, T Debniak, U Teodorczyk, T Byrski, J Gronwald, J Matyjasik, E Zlowocka, M Lenner, E Grabowska, K Nej, J Castaneda, K Medrek, A Szymańska, J Szymańska, G Kurzawski, J Suchy, O Oszurek, A Witek, S A Narod, J Lubiński. Am J Hum Genet 2004
Times Cited: 310







List of co-cited articles
711 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Hanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, Marijke Wasielewski, Anja de Snoo, Rogier Oldenburg, Antoinette Hollestelle, Mark Houben, Ellen Crepin, Monique van Veghel-Plandsoen,[...]. Nat Genet 2002
767
26

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bartłomiej Masojć, Tadeusz Deebniak, Bohdan Górski, Paweł Blecharz,[...]. J Clin Oncol 2011
125
25


CHEK2 mutations and the risk of papillary thyroid cancer.
Monika Siołek, Cezary Cybulski, Danuta Gąsior-Perczak, Artur Kowalik, Beata Kozak-Klonowska, Aldona Kowalska, Małgorzata Chłopek, Wojciech Kluźniak, Dominika Wokołorczyk, Iwona Pałyga,[...]. Int J Cancer 2015
60
31

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
19

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Maren Weischer, Stig Egil Bojesen, Christina Ellervik, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
182
17

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
472
16

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
16

Mutations in CHEK2 associated with prostate cancer risk.
Xiangyang Dong, Liang Wang, Ken Taniguchi, Xianshu Wang, Julie M Cunningham, Shannon K McDonnell, Chiping Qian, Angela F Marks, Susan L Slager, Brett J Peterson,[...]. Am J Hum Genet 2003
201
15

A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
Cezary Cybulski, Tomasz Huzarski, Bohdan Górski, Bartłomiej Masojć, Marek Mierzejewski, Tadeusz Debniak, Bartłomiej Gliniewicz, Joanna Matyjasik, Elzbieta Złowocka, Grzegorz Kurzawski,[...]. Cancer Res 2004
97
14

CHEK2 contribution to hereditary breast cancer in non-BRCA families.
Alexis Desrichard, Yannick Bidet, Nancy Uhrhammer, Yves-Jean Bignon. Breast Cancer Res 2011
48
29


Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
269
14

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
Pia Vahteristo, Jirina Bartkova, Hannaleena Eerola, Kirsi Syrjäkoski, Salla Ojala, Outi Kilpivaara, Anitta Tamminen, Juha Kononen, Kristiina Aittomäki, Päivi Heikkilä,[...]. Am J Hum Genet 2002
328
13

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.
Hanne Meijers-Heijboer, Juul Wijnen, Hans Vasen, Marijke Wasielewski, Anja Wagner, Antoinette Hollestelle, Fons Elstrodt, Renate van den Bos, Anja de Snoo, Grace Tjon A Fat,[...]. Am J Hum Genet 2003
155
12

Chk1 and Chk2 kinases in checkpoint control and cancer.
Jiri Bartek, Jiri Lukas. Cancer Cell 2003
11

CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.
Victoria Hale, Maren Weischer, Jong Y Park. Prostate Cancer 2014
32
34

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Anthony Renwick, Deborah Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard North, Hiran Jayatilake, Rita Barfoot, Katarina Spanova,[...]. Nat Genet 2006
465
11

The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis.
Chuan Liu, Ying Wang, Qing-Shui Wang, Ya-Jie Wang. Asian Pac J Cancer Prev 2012
32
34

CHK2 kinase in the DNA damage response and beyond.
Laura Zannini, Domenico Delia, Giacomo Buscemi. J Mol Cell Biol 2014
173
11

Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase.
Zhenjian Cai, Nabil H Chehab, Nikola P Pavletich. Mol Cell 2009
101
10

Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility.
He-ping Xiang, Xiao-ping Geng, Wei-wei Ge, He Li. Eur J Cancer 2011
42
23

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.
D W Bell, J M Varley, T E Szydlo, D H Kang, D C Wahrer, K E Shannon, M Lubratovich, S J Verselis, K J Isselbacher, J F Fraumeni,[...]. Science 1999
652
10

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Siân Jones, Ralph H Hruban, Mihoko Kamiyama, Michael Borges, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Emily Palmisano, Kieran Brune, Elizabeth M Jaffee,[...]. Science 2009
523
10

The risk of gastric cancer in carriers of CHEK2 mutations.
Urszula Teodorczyk, Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Teresa Starzyńska, Małgorzata Lawniczak, Paweł Domagała, Katarzyna Ferenc, Krzysztof Marlicz, Zbigniew Banaszkiewicz,[...]. Fam Cancer 2013
31
32

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.
C Cybulski, D Wokołorczyk, T Huzarski, T Byrski, J Gronwald, B Górski, T Debniak, B Masojć, A Jakubowska, B Gliniewicz,[...]. J Med Genet 2006
75
13

Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005
317
10

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.
Marjanka K Schmidt, Frans Hogervorst, Richard van Hien, Sten Cornelissen, Annegien Broeks, Muriel A Adank, Hanne Meijers, Quinten Waisfisz, Antoinette Hollestelle, Mieke Schutte,[...]. J Clin Oncol 2016
74
13

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
10

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.
Maren Weischer, Børge G Nordestgaard, Paul Pharoah, Manjeet K Bolla, Heli Nevanlinna, Laura J Van't Veer, Montserrat Garcia-Closas, John L Hopper, Per Hall, Irene L Andrulis,[...]. J Clin Oncol 2012
103
9


CHEK2 mutations and HNPCC-related colorectal cancer.
Janina Suchy, Cezary Cybulski, Dominika Wokołorczyk, Oleg Oszurek, Bohdan Górski, Tadeusz Debniak, Anna Jakubowska, Jacek Gronwald, Tomasz Huzarski, Tomasz Byrski,[...]. Int J Cancer 2010
26
34

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
564
8

Increased risk of breast cancer associated with CHEK2*1100delC.
Maren Weischer, Stig Egil Bojesen, Anne Tybjaerg-Hansen, Christen Kirk Axelsson, Børge Grønne Nordestgaard. J Clin Oncol 2007
78
10

DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
A Hirao, Y Y Kong, S Matsuoka, A Wakeham, J Ruland, H Yoshida, D Liu, S J Elledge, T W Mak. Science 2000
961
8

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland.
Cezary Cybulski, Dominika Wokołorczyk, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bohdan Górski, Tadeusz Debniak, Bartłomiej Masojć, Anna Jakubowska, Thierry van de Wetering,[...]. Breast Cancer Res Treat 2007
78
10

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
Silvia Casadei, Barbara M Norquist, Tom Walsh, Sunday Stray, Jessica B Mandell, Ming K Lee, John A Stamatoyannopoulos, Mary-Claire King. Cancer Res 2011
166
8

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
8

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
8

Rare variants in the ATM gene and risk of breast cancer.
David E Goldgar, Sue Healey, James G Dowty, Leonard Da Silva, Xiaoqing Chen, Amanda B Spurdle, Mary Beth Terry, Mary J Daly, Saundra M Buys, Melissa C Southey,[...]. Breast Cancer Res 2011
125
8

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006
435
8

CHEK2 variant I157T may be associated with increased breast cancer risk.
Outi Kilpivaara, Pia Vahteristo, Jacob Falck, Kirsi Syrjäkoski, Hannaleena Eerola, Douglas Easton, Jirina Bartkova, Jiri Lukas, Päivi Heikkilä, Kristiina Aittomäki,[...]. Int J Cancer 2004
107
8

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
240
8

Response to DNA damage of CHEK2 missense mutations in familial breast cancer.
Wendy Roeb, Jake Higgins, Mary-Claire King. Hum Mol Genet 2012
41
19

Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers.
Tracey P Leedom, Holly LaDuca, Rachel McFarland, Shuwei Li, Jill S Dolinsky, Elizabeth C Chao. Cancer Genet 2016
21
38

Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
S B Lee, S H Kim, D W Bell, D C Wahrer, T A Schiripo, M M Jorczak, D C Sgroi, J E Garber, F P Li, K E Nichols,[...]. Cancer Res 2001
120
8

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
252
7

Hereditary breast cancer: the era of new susceptibility genes.
Paraskevi Apostolou, Florentia Fostira. Biomed Res Int 2013
133
7

CHEK2 variants associate with hereditary prostate cancer.
E H Seppälä, T Ikonen, N Mononen, V Autio, A Rökman, M P Matikainen, T L J Tammela, J Schleutker. Br J Cancer 2003
102
7

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
J Falck, N Mailand, R G Syljuåsen, J Bartek, J Lukas. Nature 2001
780
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.